Thyroid News

More than 95% of adults with low-risk papillary thyroid cancer were disease-free after radiofrequency ablation, according to findings from a single-center study published in Thyroid.

Hemithyroidectomy is associated with better quality of life after surgery than total thyroidectomy for adults with low-risk differentiated thyroid cancer, though more studies are needed, according to findings from a systematic review.

Adults have a decreased risk for developing autoimmune thyroid disease after being diagnosed with rheumatoid arthritis, with the risk even lower for those receiving disease-modifying antirheumatic drugs, according to study data.

Thyroid-stimulating hormone testing rates remained stable in the U.S. from 2006 to 2020, with about 10% of adults without thyroid disease receiving a test annually, according to study data.

Teprotumumab has marked the dawn of a new era in the treatment of thyroid eye disease.

Until recently, patients with active thyroid eye disease had limited options for treatment of their condition besides observation.

Exposure to a class of endocrine-disrupting chemicals may increase the risk for developing thyroid cancer, according to a study published in eBioMedicine.

Adults with long-standing thyroid eye disease and low clinical activity scores had greater reductions in proptosis with teprotumumab compared with placebo, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Adults with Graves’ disease do not have an increased risk for an osteoporosis-related fracture later in life compared with those without Graves’ disease, according to data from a retrospective study published in Thyroid.

MADRID — Selpercatinib improved outcomes compared with cabozantinib or vandetanib for treatment of RET-mutant medullary thyroid cancer, according to randomized phase 3 study results presented at ESMO Congress.